{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:55:31Z","timestamp":1789966531688,"version":"4.0.1"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Public Health Agency of Canada in association with Neurological Health Charities Canada through a contribution agreement administered through the University of Ottawa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.neuro.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T07:02:01Z","timestamp":1484895721000},"page":"79-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Risk factors for the onset and progression of Huntington disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Ting-Kuang","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Pringsheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2017.01.005_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000070854","article-title":"DNA testing for Huntington disease in the Turkish population","volume":"50","author":"Akbas","year":"2003","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0010","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1212\/01.wnl.0000175977.57661.b1","article-title":"Association between BDNF Val66Met polymorphism and age at onset in Huntington disease","volume":"65","author":"Alberch","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/hmg\/4.2.207","article-title":"Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease","volume":"4","author":"Almqvist","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0020","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/mds.22737","article-title":"Clinical and genetic characteristics of Mexican Huntington\u2019s disease patients","volume":"24","author":"Alonso","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1469-1809.2006.00335.x","article-title":"The relationship between CAG repeat length and, age of onset differs for Huntington\u2019s disease patients with juvenile onset or adult onset","volume":"71","author":"Andresen","year":"2007","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0030","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nature Genet."},{"issue":"1","key":"10.1016\/j.neuro.2017.01.005_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/fnl.11.65","article-title":"Genetic modifiers of Huntington\u2019s disease: beyond CAG?","volume":"7","author":"Arning","year":"2012","journal-title":"Future Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-010-0589-2","article-title":"Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease","volume":"88","author":"Arning","year":"2010","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neuro.2017.01.005_bib0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1212\/WNL.44.6.1137","article-title":"CAG repeat size and clinical presentation in Huntington\u2019s disease","volume":"44","author":"Ashizawa","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0404.1999.tb00738.x","article-title":"The genetic analysis of Turkish patients with Huntington\u2019s disease","volume":"100","author":"Atac","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuro.2017.01.005_bib0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mds.22907","article-title":"The relationship between uric acid levels and Huntington\u2019s disease progression","volume":"25","author":"Auinger","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0060","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/WNL.0b013e3181bd1121","article-title":"Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease","volume":"73","author":"Aziz","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0065","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/j.ejmg.2011.04.002","article-title":"Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington\u2019s disease","volume":"54","author":"Aziz","year":"2011","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0070","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/jmg.30.12.1003","article-title":"A study of the Huntington\u2019s disease associated trinucleotide repeat in the Scottish population","volume":"30","author":"Barron","year":"1993","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/hmg\/3.1.173","article-title":"A single allele from the polymorphic CCG rich sequence immediately 3' to the unstable CAG trinucleotide in the IT15 cDNA shows almost complete disequilibrium with Huntington\u2019s disease chromosomes in the Scottish population","volume":"3","author":"Barron","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.46.2.527","article-title":"Trinucleotide repeat length, clinical progression in Huntington\u2019s disease","volume":"46","author":"Brandt","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0085","first-page":"1202","article-title":"The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size","volume":"60","author":"Brinkman","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ajmg.b.30826","article-title":"Repeat instability in the 27\u201339 CAG range of the HD gene in the Venezuelan kindreds: counseling implications","volume":"150B","author":"Brocklebank","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-7091-0579-5_12","article-title":"Methyltetrahydrofolate reductase polymorphism influences onset of Huntington\u2019s disease","volume":"68","author":"Brune","year":"2004","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neuro.2017.01.005_bib0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0022-510X(87)90164-X","article-title":"Which factors influence age at onset, rate of progression in Huntington\u2019s disease","volume":"80","author":"Buruma","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajmg.b.20110","article-title":"The gender effect in juvenile Huntington disease patients of Italian origin","volume":"125B","author":"Cannella","year":"2004","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2004.10.018","article-title":"Modulation of age at onset of Huntington disease patients by variations in TP53, human caspase activated DNase (hCAD) genes","volume":"374","author":"Chattopadhyay","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2017.01.005_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-1","article-title":"Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease","volume":"6","author":"Che","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuro.2017.01.005_bib0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/hmg\/6.2.301","article-title":"Contribution of DNA sequence, CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses","volume":"6","author":"Chong","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ng1193-254","article-title":"Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I","volume":"5","author":"Chung","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0130","first-page":"172","article-title":"Late onset Huntington\u2019s disease: clinical, genetic characteristics of 20 cases","volume":"16","author":"Cislaghi","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archneur.1995.00540320021009","article-title":"Correlations between triplet repeat expansion, clinical features in Huntington\u2019s disease","volume":"52","author":"Claes","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tox.2009.10.019","article-title":"The hOGG1 Ser326Cys polymorphism, Huntington\u2019s disease","volume":"278","author":"Coppede","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0145","first-page":"1878","article-title":"Changes on the dementia rating scale (drs) over time in Huntington\u2019s disease","volume":"24","author":"Corey-Bloom","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0150","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.ejhg.5201055","article-title":"Molecular diagnosis of Huntington disease in Portugal: implications for genetic counselling, clinical practice","volume":"11","author":"Costa","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10038-005-0343-8","article-title":"The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics, to the origin of the mutation","volume":"51","author":"Costa","year":"2006","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0160","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jmg.30.12.996","article-title":"Dynamic mutation in Dutch Huntington\u2019s disease patients: increased paternal repeat instability extending to within the normal size range","volume":"30","author":"De Rooij","year":"1993","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0165","first-page":"175","article-title":"The one-year progression of juvenileonset Huntington\u2019s disease (JHD) in relation to manifestation of the first symptom","volume":"16","author":"Dec","year":"2009","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2009.06.009","article-title":"A genetic variation in the ADORA2A gene modifies age at onset in Huntington\u2019s disease","volume":"35","author":"Dhaenens","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2017.01.005_bib0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.a.20190","article-title":"Interaction of normal, exp,ed CAG repeat sizes influences age at onset of Huntington disease","volume":"119A","author":"Djouss\u00e9","year":"2003","journal-title":"Am. J. Med Genet. A."},{"key":"10.1016\/j.neuro.2017.01.005_bib0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/jnp.2010.22.2.196","article-title":"Frontal behaviors before the diagnosis of Huntington\u2019s disease, their relationship to markers of disease progression: evidence of early lack of awareness","volume":"22","author":"Duff","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ng0893-387","article-title":"Trinucleotide repeat length instability, age of onset in Huntington\u2019s disease","volume":"4","author":"Duyao","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugalcdep.2006.06.009","article-title":"Huntington disease as a dual diagnosis disorder Data from the national research roster for Huntington disease patients, families","volume":"86","author":"Ehret","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuro.2017.01.005_bib0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.870100213","article-title":"Functional decline in Huntington\u2019s disease","volume":"10","author":"Feigin","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","article-title":"Differences in duration of Huntington\u2019s disease based on age at onset","volume":"66","author":"Foroud","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ana.410390120","article-title":"Relationship between trinucleotide repeats, neuropathological changes in Huntington\u2019s disease","volume":"39","author":"Furtado","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0210","first-page":"19","article-title":"Trinucleotide repeat length, clinical progression in Huntington\u2019s disease","volume":"13","author":"G\u00fcnal","year":"2000","journal-title":"Marmara Med. J."},{"key":"10.1016\/j.neuro.2017.01.005_bib0215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/humu.20167","article-title":"Ancient origin of the CAG expansion causing Huntington disease in a Spanish population","volume":"25","author":"Garc\u00eda-Planells","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuro.2017.01.005_bib0220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1098-1004(1997)10:6<458::AID-HUMU7>3.0.CO;2-9","article-title":"Analysis of (CAG)n size heterogeneity in somatic, sperm cell DNA from intermediate, exp,ed Huntington disease gene carriers","volume":"10","author":"Giovannone","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuro.2017.01.005_bib0225","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/4.10.1911","article-title":"Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population","volume":"4","author":"Goldberg","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.74.1.120","article-title":"Behavioural abnormalities contribute to functional decline in Huntington\u2019s disease","volume":"74","author":"Hamilton","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp-2011-301732","article-title":"Cognitive domains that predict time to diagnosis in prodromal Huntington disease","volume":"83","author":"Harrington","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0240","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/humu.9055","article-title":"Genetic background of huntington disease in Croatia: molecular analysis of CAG, CCG, Delta2642 (E2642del) polymorphisms","volume":"20","author":"He\u0107imovi\u0107","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuro.2017.01.005_bib0245","first-page":"S55","article-title":"Cognitive decline in Huntington\u2019s disease is associated with CAG repeat length","volume":"27","author":"Hellman","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00415-009-0052-x","article-title":"Relationship between CAG repeat length, brain volume in premanifest, early Huntington\u2019s disease","volume":"256","author":"Henley","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuro.2016.06.017","article-title":"Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: a methodological overview","volume":"61","author":"Hersi","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0260","first-page":"53","article-title":"Molecular analysis of the (CAG)n repeat causing Huntington\u2019s disease in 34 Iranian families","volume":"10","author":"Hormozian","year":"2004","journal-title":"Ind. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0265","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.410360412","article-title":"Trinucleotide repeat length, rate of progression of Huntington\u2019s disease","volume":"36","author":"Illarioshkin","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0270","doi-asserted-by":"crossref","first-page":"A29","DOI":"10.1136\/jnnp.2010.222620.22","article-title":"An assessment of alcohol abuse on cognitive abilities, executive functions, motor signs in Huntington\u2019s disease","volume":"81","author":"Irving","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ageing\/23.6.445","article-title":"Late-onset Huntington\u2019s disease: a clinical, molecular study","volume":"23","author":"James","year":"1994","journal-title":"Age Ageing"},{"key":"10.1016\/j.neuro.2017.01.005_bib0280","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archneur.1997.00550210019008","article-title":"Cognitive manifestations of Huntington disease in relation to genetic structure, clinical onset","volume":"54","author":"Jason","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0285","first-page":"335","article-title":"Late-onset, typical Huntington disease families from Crete have distinct genetic origins","volume":"17","author":"Kartsaki","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuro.2017.01.005_bib0290","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jmg.31.11.872","article-title":"Trinucleotide repeat length, progression of illness in Huntington\u2019s disease","volume":"31","author":"Kieburtz","year":"1994","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","article-title":"Progression of symptoms in the early, middle stages of Huntington disease","volume":"58","author":"Kirkwood","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0300","first-page":"217","article-title":"Unified Huntington\u2019s disease rating scale: clinical practice, a critical approach","volume":"21","author":"Klempir","year":"2006","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0305","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/jmg.30.12.991","article-title":"Molecular analysis of late onset Huntington\u2019s disease","volume":"30","author":"Kremer","year":"1993","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0310","first-page":"343","article-title":"Sex-dependent mechanisms for expansions, contractions of the CAG repeat on affected Huntington disease chromosomes","volume":"57","author":"Kremer","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0315","first-page":"20","article-title":"Identification of genetic modifiers of age of onset, progression in HD","volume":"80","author":"Lahiri","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0320","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajhg.2012.01.005","article-title":"Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region","volume":"90","author":"Lee","year":"2012","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0325","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/hmg\/4.9.1519","article-title":"Single sperm analysis of the trinucleotide repeats in the Huntington\u2019s disease gene: quantification of the mutation frequency spectrum","volume":"4","author":"Leeflang","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/hmg\/8.2.173","article-title":"Analysis of germline mutation spectra at the Huntington\u2019s disease locus supports a mitotic mutation mechanism","volume":"8","author":"Leeflang","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0335","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000472340","article-title":"Limited expansion of the (CAG)n repeat of the huntington gene: a premutation (?)","volume":"2","author":"Legius","year":"1994","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S0004-282X2000000100002","article-title":"Molecular diagnosis of Huntington disease in Brazilian patients","volume":"58","author":"Lima","year":"2000","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neuro.2017.01.005_bib0345","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jns.2008.09.029","article-title":"Late onset Huntington disease: clinical, genetic characteristics of 34 cases","volume":"276","author":"Lipe","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0350","first-page":"321","article-title":"Trinucleotide repeat elongation in the huntingtin gene in Huntington\u2019s disease patients from 85 French families","volume":"5","author":"Lucotte","year":"1994","journal-title":"Genet. Couns."},{"key":"10.1016\/j.neuro.2017.01.005_bib0355","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00209410","article-title":"Confidence intervals for predicted age of onset, given the size of (CAG)n repeat, in Huntington\u2019s disease","volume":"95","author":"Lucotte","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0360","first-page":"297","article-title":"Relationships of the 2642 deletion polymorphism (delta 2642) in the huntingtin gene with the CAG repeat expansion length, age at onset of the disease","volume":"7","author":"Lucotte","year":"1996","journal-title":"Genet. Couns."},{"key":"10.1016\/j.neuro.2017.01.005_bib0365","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2010.08.024","article-title":"Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population","volume":"298","author":"Ma","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0370","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00005792-200207000-00001","article-title":"Predictability of age at onset in Huntington disease in the Dutch population","volume":"81","author":"Maat-Kievit","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neuro.2017.01.005_bib0375","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/jmg.30.12.982","article-title":"Gametic but not somatic instability of CAG repeat length in Huntington\u2019s disease","volume":"30","author":"MacDonald","year":"1993","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0380","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.53.6.1330","article-title":"Evidence for the GluR6 gene associated with younger onset age of Huntington\u2019s disease","volume":"53","author":"MacDonald","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0385","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","article-title":"Huntington\u2019s disease Clinical correlates of disability, progression","volume":"61","author":"Mahant","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0390","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2008.08.013","article-title":"Mitochondrial DNA haplogroups do not influence the Huntington\u2019s disease phenotype","volume":"444","author":"Mancuso","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2017.01.005_bib0395","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.54.2.452","article-title":"Rate of functional decline in Huntington\u2019s disease","volume":"54","author":"Marder","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0400","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/01.WNL.0000035627.16789.23","article-title":"Relationship between CAG repeat length, late-stage outcomes in Huntington\u2019s disease","volume":"59","author":"Marder","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0405","first-page":"199","article-title":"Plasma testosterone, dehydroepi, rosterone sulfate, cortisol in female patients with Huntington\u2019s disease","volume":"28","author":"Markianos","year":"2007","journal-title":"Neurol. Endocrinol. Lett."},{"key":"10.1016\/j.neuro.2017.01.005_bib0410","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/jmg.32.9.701","article-title":"Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington\u2019s disease","volume":"32","author":"Masuda","year":"1995","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0415","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ana.410200613","article-title":"Correlates of early disability in Huntington\u2019s disease","volume":"20","author":"Mayeux","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0420","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/hmg\/6.5.775","article-title":"Reduced penetrance of the Huntington\u2019s disease mutation","volume":"6","author":"McNeil","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0425","first-page":"CD006455","article-title":"Therapeutic interventions for disease progression in Huntington\u2019s disease","volume":"3","author":"Mestre","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuro.2017.01.005_bib0430","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/ddn003","article-title":"Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington\u2019s disease","volume":"17","author":"Metzger","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0435","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.arcmed.2007.06.015","article-title":"Analysis of CCG repeats in Huntingtin gene among HD patients and normal populations in Japan","volume":"39","author":"Morovvati","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuro.2017.01.005_bib0440","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(01)00593-7","article-title":"A clinical study of patients with genetically confirmed Huntington\u2019s disease from India","volume":"190","author":"Murgod","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0445","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.38.3.341","article-title":"Clinical and neuropathologic assessment of severity in Huntington\u2019s disease","volume":"38","author":"Myers","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0450","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington\u2019s disease","volume":"48","author":"Myers","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(02)00231-8","article-title":"Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington\u2019s disease","volume":"328","author":"Naze","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2017.01.005_bib0460","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/jnp.13.3.342","article-title":"Effects of depression on working memory in presymptomatic Huntington\u2019s disease","volume":"13","author":"Nehl","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0465","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1469-1809.1981.tb00352.x","article-title":"Factors influencing age at onset and duration of survival in Huntington\u2019s chorea","volume":"45","author":"Newcombe","year":"1981","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0470","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/2.9.1475","article-title":"Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families","volume":"2","author":"Norremolle","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0475","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-0004.1995.tb03941.x","article-title":"Correlation between magnitude of CAG repeat length alterations and length of the paternal repeat in paternally inherited Huntington\u2019s disease","volume":"47","author":"Norremolle","year":"1995","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0480","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1399-0004.2008.01136.x","article-title":"4p16.3 haplotype modifying age at onset of Huntington disease","volume":"75","author":"Norremolle","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0485","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/hmg\/3.1.93","article-title":"Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease","volume":"3","author":"Novelletto","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0490","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/hmg\/3.7.1129","article-title":"Polymorphism analysis of the huntingtin gene in Italian families affected with Huntington disease","volume":"3","author":"Novelletto","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0495","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/arclin\/acq088","article-title":"Estimating premorbid functioning in Huntington\u2019s disease: the relationship between disease progression and the Wide Range Achievement Test Reading Subtest","volume":"26","author":"O'Rourke","year":"2011","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0500","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13803395.2010.541228","article-title":"The Trail Making Test in prodromal Huntington disease: contributions of disease progression to test performance","volume":"33","author":"O'Rourke","year":"2011","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0505","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1034\/j.1399-0004.2001.590210.x","article-title":"The \u2018flap' endonuclease gene FEN1 is excluded as a candidate gene implicated in the CAG repeat expansion underlying Huntington disease","volume":"59","author":"Otto","year":"2001","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0510","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s004150050406","article-title":"Apolipoprotein E and presenilin-1 genotypes in Huntington\u2019s disease","volume":"246","author":"Panas","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0515","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000093867","article-title":"A study of potential interactive genetic factors in Huntington\u2019s disease","volume":"55","author":"Panegyres","year":"2006","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0520","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrg1689","article-title":"Repeat instability: mechanisms of dynamic mutations","volume":"6","author":"Pearson","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0525","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10654-007-9157-7","article-title":"Survival of Huntington\u2019s disease patients in Serbia: longer survival in female patients","volume":"22","author":"Pekmezovic","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0530","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mds.870050202","article-title":"Huntington\u2019s disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals","volume":"5","author":"Penney","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0535","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/nbdi.1994.0019","article-title":"Huntington\u2019s disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains","volume":"1","author":"Persichetti","year":"1994","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2017.01.005_bib0540","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/eje.0.1510451","article-title":"Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington\u2019s disease","volume":"151","author":"Popovic","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0545","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.ejhg.5200515","article-title":"Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India","volume":"8","author":"Pramanik","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0550","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0555","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/mds.24065","article-title":"Intergenerational instability in Huntington disease: extreme repeat changes among 134 transmissions","volume":"27","author":"Ramos","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0560","first-page":"593","article-title":"Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease","volume":"57","author":"Ranen","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0565","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/mds.21988","article-title":"The relationship between CAG repeat length and clinical progression in Huntington\u2019s disease","volume":"23","author":"Ravina","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0570","doi-asserted-by":"crossref","first-page":"A30","DOI":"10.1136\/jnnp.2010.222620.23","article-title":"Incidence, course and predictors of apathy in Huntington\u2019s disease: a 2-year prospective study","volume":"81","author":"Reedeker","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0575","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psym.2011.12.010","article-title":"Psychiatric disorders in Huntington\u2019s disease: a 2-year follow-up study","volume":"53","author":"Reedeker","year":"2012","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuro.2017.01.005_bib0580","doi-asserted-by":"crossref","first-page":"A21","DOI":"10.1136\/jnnp.2010.22638.3","article-title":"Determinants of survival in Huntington\u2019s disease","volume":"81","author":"Rinaldi","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0585","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S0317167100012671","article-title":"Predictors of survival in a Huntington\u2019s disease population from southern Italy","volume":"39","author":"Rinaldi","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0590","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp.56.1.98","article-title":"Duration of illness in Huntington\u2019s disease is not related to age at onset","volume":"56","author":"Roos","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0595","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ajmg.1400","article-title":"Familial influence on age of onset among siblings with Huntington disease","volume":"105","author":"Rosenblatt","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0600","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ana.10691","article-title":"Predictors of neuropathological severity in 100 patients with Huntington\u2019s disease","volume":"54","author":"Rosenblatt","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0605","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0610","first-page":"1711","article-title":"Factors contributing to institutionalization in patients with Huntington\u2019s disease","volume":"26","author":"Rosenblatt","year":"2011","journal-title":"MovDisord"},{"key":"10.1016\/j.neuro.2017.01.005_bib0615","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mds.24024","article-title":"Age, CAG repeat length, clinical progression in Huntington\u2019s disease","volume":"27","author":"Rosenblatt","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0620","first-page":"127","article-title":"Caudate nucleus atrophy in Huntington\u2019s disease and its relationship with clinical and genetic parameters","volume":"20","author":"Roth","year":"2005","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0625","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/2.10.1713","article-title":"Analysis of the huntingtin gene revels a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington\u2019s disease and CAG repeat number","volume":"2","author":"Rubinsztein","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0630","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng0894-525","article-title":"Mutational bias provides a model for the evolution of Huntington\u2019s disease and predicts a general increase in disease prevalence","volume":"7","author":"Rubinsztein","year":"1994","journal-title":"Nature Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0635","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/hmg\/4.2.203","article-title":"Haplotype analysis of the delta 2642 and (CAG)n polymorphisms in the Huntington\u2019s disease (HD) gene provides an explanation for an apparent \u2018founder' HD haplotype","volume":"4","author":"Rubinsztein","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0640","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1073\/pnas.94.8.3872","article-title":"Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease","volume":"94","author":"Rubinsztein","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuro.2017.01.005_bib0645","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1590\/S0100-879X2006000800016","article-title":"Striatal and extrastriatal atrophy in Huntington\u2019s disease and its relationship with length of the CAG repeat","volume":"39","author":"Ruocco","year":"2006","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuro.2017.01.005_bib0650","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/jnnp.2007.116244","article-title":"Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat","volume":"79","author":"Ruocco","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.01.005_bib0655","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/jnnp.2009.176982","article-title":"Progression in prediagnostic Huntington disease","volume":"81","author":"Rupp","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neuro.2017.01.005_bib0660","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0404.2003.00133.x","article-title":"Molecular analysis of Huntington\u2019s disease and linked polymorphisms in the Indian population","volume":"108","author":"Saleem","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuro.2017.01.005_bib0665","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","article-title":"High insulinlike growth factor I is associated with cognitive decline in Huntington disease","volume":"75","author":"Saleh","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.01.005_bib0670","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ajmg.b.30970","article-title":"Unstable familial transmissions of Huntington disease alleles with 27\u201335 CAG repeats (intermediate alleles)","volume":"153B","author":"Semaka","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0675","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1399-0004.2010.01388.x","article-title":"Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population","volume":"78","author":"Sequeiros","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0680","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(97)00182-1","article-title":"Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington\u2019s disease","volume":"225","author":"Sieradzan","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuro.2017.01.005_bib0685","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0887-8994(97)00069-6","article-title":"Juvenile huntington disease in the Netherlands","volume":"17","author":"Siesling","year":"1997","journal-title":"Pediatric Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0690","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/jmg.30.12.1014","article-title":"Huntington\u2019s disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease","volume":"30","author":"Simpson","year":"1993","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0695","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng0893-393","article-title":"Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease","volume":"4","author":"Snell","year":"1993","journal-title":"Nature Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0700","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/mds.22097","article-title":"Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease","volume":"23","author":"Solomon","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0705","first-page":"137","article-title":"A study on Huntington\u2019s disease associated trinucleotide repeat within the Chinese population","volume":"19","author":"Soong","year":"1995","journal-title":"Proc. Natl. Sci. Counc. Repub. China B"},{"key":"10.1016\/j.neuro.2017.01.005_bib0710","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/hmg\/3.12.2103","article-title":"DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence","volume":"3","author":"Squitieri","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0715","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/1096-8628(20001211)95:4<366::AID-AJMG13>3.0.CO;2-2","article-title":"Family and molecular data for a fine analysis of age at onset in Huntington disease","volume":"95","author":"Squitieri","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0720","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1007\/s100720200092","article-title":"CAG mutation effect on rate of progression in Huntington\u2019s disease","volume":"23","author":"Squitieri","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0725","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","article-title":"Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course","volume":"126","author":"Squitieri","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2017.01.005_bib0730","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/2.10.1547","article-title":"Correlation between the onset age of Huntington\u2019s disease and length of the trinucleotide repeat in IT-15","volume":"2","author":"Stine","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0735","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/hmg\/2.10.1535","article-title":"Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent","volume":"2","author":"Telenius","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0740","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ng0494-409","article-title":"Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm","volume":"6","author":"Telenius","year":"1994","journal-title":"Nature Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0745","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/hmg\/4.2.189","article-title":"Somatic mosaicism in sperm is associated with intergenerational (CAG)n changes in Huntington disease","volume":"4","author":"Telenius","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0750","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","article-title":"Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease","volume":"24","author":"Thompson","year":"2012","journal-title":"J. Neuropsych. Clin. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.neuro.2017.01.005_bib0755","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/brain\/awl243","article-title":"Striosomes and mood dysfunction in Huntington\u2019s disease","volume":"130","author":"Tippett","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2017.01.005_bib0760","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/mds.23108","article-title":"A retrospective study of the impact of lifestyle on age at onset of Huntington disease","volume":"25","author":"Trembath","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0765","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jmg.31.5.377","article-title":"Instability of CAG repeats in Huntington\u2019s disease: relation to parental transmission and age of onset","volume":"31","author":"Trottier","year":"1994","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0770","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1590\/S0004-282X2004000600009","article-title":"Internal consistency of a Brazilian version of the unified Huntington\u2019s disease rating scale","volume":"62","author":"Tumas","year":"2004","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.neuro.2017.01.005_bib0775","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/hmg\/4.12.2239","article-title":"Stability of the Huntington disease (CAG)n repeat in a late-onset form occurring on the Island of Crete","volume":"4","author":"Tzagournissakis","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0780","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jpsychires.2007.05.008","article-title":"Effect of CAG repeat length on psychiatric disorders in Huntington\u2019s disease","volume":"42","author":"Vassos","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuro.2017.01.005_bib0785","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.dnarep.2007.01.002","article-title":"Inherited CAG. CTG allele length is a major modifier of somatic mutation length variability in Huntington disease","volume":"6","author":"Veitch","year":"2007","journal-title":"DNA Repair"},{"key":"10.1016\/j.neuro.2017.01.005_bib0790","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jnnp.64.6.758","article-title":"Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington\u2019s disease","volume":"64","author":"Vuillaume","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuro.2017.01.005_bib0795","first-page":"S61","article-title":"MAPT genotype and its influence on cognitive decline in Huntington\u2019s disease","volume":"27","author":"Vuono","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2017.01.005_bib0800","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000079938","article-title":"DNA haplotype analysis of CAG repeat in Taiwanese Huntington\u2019s disease patients","volume":"52","author":"Wang","year":"2004","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0805","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","article-title":"CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup","volume":"84","author":"Warby","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0810","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ejhg.2010.229","article-title":"HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia","volume":"19","author":"Warby","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0815","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1355617706060565","article-title":"A four-year prospective study of cognitive functioning in Huntington\u2019s disease","volume":"12","author":"Ward","year":"2006","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neuro.2017.01.005_bib0820","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1136\/jnnp.2010.222620.10","article-title":"Correlations between functional measures, voluntary and involuntary motor symptoms in HD-multivariate analysis of cross-sectional and longitudinal registry","volume":"81","author":"Waters","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neuro.2017.01.005_bib0825","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuro.2017.01.005_bib0830","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.050930","article-title":"Factors associated with HD CAG repeat instability in Huntington disease","volume":"44","author":"Wheeler","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0835","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/109065700316480","article-title":"Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability","volume":"4","author":"Williams","year":"2000","journal-title":"Genet. Test."},{"key":"10.1016\/j.neuro.2017.01.005_bib0840","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jocn.2009.03.027","article-title":"Polymorphism of HD and UCHL-1 genes in Huntington\u2019s disease","volume":"16","author":"Xu","year":"2009","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neuro.2017.01.005_bib0845","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000472303","article-title":"Linkage disequilibrium between the expanded (CAG)n repeat and an allele of the adjacent (CCG)n repeat in Huntington\u2019s disease patients of Greek origin","volume":"3","author":"Yapijakis","year":"1995","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuro.2017.01.005_bib0850","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archneur.1996.00550060035012","article-title":"Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington\u2019s disease","volume":"53","author":"Zappacosta","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuro.2017.01.005_bib0855","first-page":"688","article-title":"Gender differences in the CAG repeats and clinical picture correlations in Huntington\u2019s disease","volume":"71","author":"Zielonka","year":"2008","journal-title":"Ceska a Slovenska Neurologie a Neurochirurgie"},{"key":"10.1016\/j.neuro.2017.01.005_bib0860","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/2.12.2063","article-title":"Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene","volume":"2","author":"Zuhlke","year":"1993","journal-title":"Hum. Mol. Genet."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X17300165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X17300165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T17:45:19Z","timestamp":1749923119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X17300165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":172,"alternative-id":["S0161813X17300165"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2017.01.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for the onset and progression of Huntington disease","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}